MedTrace Logo

Evaluation of Remnant Cholesterol Levels and Monocyte-to-HDL-cholesterol Ratio As Predictors of Coronary Artery Disease Severity in Patients with Acute Coronary Syndrome

NCT06757777 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2025-02-11

No results posted yet for this study

Summary

1. Evaluation of serum level of remnant cholesterol and monocyte/HDL ratio as predictors of severity of coronary artery disease in patients with acute coronary syndrome.
2. Evaluate predictive value of remnant cholesterol serum level and monocyte/HDL ratio to detect in-hospital worse clinical outcomes and 45 days major adverse cardiac events (MACE) after acute coronary syndrome.

Conditions

  • Acute Coronary Syndrome
  • ACS (acute Coronary Syndrome)
  • Monocyte to HDL Cholesterol Ratio
  • STEMI
  • Non STEMI

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Isaac A Ghaly, Resident · Assiut University

  • Hanan A Mahmoud, Lecturer · Assiut University

  • Khaled A Mohamed, Lecturer · Assiut University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-08
Primary Completion
2026-02-08
Completion
2026-03-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06757777 on ClinicalTrials.gov